Cargando…

SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin

Unactivated partial thromboplastin antecedent (PTA) has been purified by sequential chromatography of plasma on quaternary aminoethyl Sephadex, sulphoprophyl Sephadex, Sephadex G-150, and passage over an anti-IgG immunoadsorbant. The preparation gave a single band after alkaline disc gel electrophor...

Descripción completa

Detalles Bibliográficos
Autores principales: Heck, Louis W., Kaplan, Allen P.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1974
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139762/
https://www.ncbi.nlm.nih.gov/pubmed/4547783
_version_ 1782143872081592320
author Heck, Louis W.
Kaplan, Allen P.
author_facet Heck, Louis W.
Kaplan, Allen P.
author_sort Heck, Louis W.
collection PubMed
description Unactivated partial thromboplastin antecedent (PTA) has been purified by sequential chromatography of plasma on quaternary aminoethyl Sephadex, sulphoprophyl Sephadex, Sephadex G-150, and passage over an anti-IgG immunoadsorbant. The preparation gave a single band after alkaline disc gel electrophoresis, sodium dodecyl sulfate (SDS) gel electrophoresis and isoelectric focusing in acrylamide gels and was found to have a mol wt of 175,000 by gel filtration, 163,000 by SDS gel electrophoresis, and an isoelectric point of 8.8–9.4 (peak 9.0–9.1). Pre-PTA was activated directly by activated Hageman factor or by Hageman factor prealbumin fragments. Its coagulant activity was inhibited by DFP, soybean trypsin inhibitor and trasylol but not by lima bean trypsin inhibitor or ovomucoid trypsin inhibitor indicating that activated PTA possesses the same inhibition profile utilizing these reagents as does plasma kallikrein. A major plasma inhibitor of activated PTA was found to be a 65,000 mol wt α-globulin which was isolated free of α(1)-chymotrypsin inhibitor, inter α-trypsin inhibitor, α(2)-macroglobulin, and the other known inhibitors of activated PTA, the activated first component of complement (C1 INH), and antithrombin III. Its physicochemical properties were identical to α(1)-antitrypsin, and it was absent in α(1)-antitrypsin-deficient plasma thereby identifying this PTA inhibitor as α(1)-antitrypsin.
format Text
id pubmed-2139762
institution National Center for Biotechnology Information
language English
publishDate 1974
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21397622008-04-17 SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin Heck, Louis W. Kaplan, Allen P. J Exp Med Article Unactivated partial thromboplastin antecedent (PTA) has been purified by sequential chromatography of plasma on quaternary aminoethyl Sephadex, sulphoprophyl Sephadex, Sephadex G-150, and passage over an anti-IgG immunoadsorbant. The preparation gave a single band after alkaline disc gel electrophoresis, sodium dodecyl sulfate (SDS) gel electrophoresis and isoelectric focusing in acrylamide gels and was found to have a mol wt of 175,000 by gel filtration, 163,000 by SDS gel electrophoresis, and an isoelectric point of 8.8–9.4 (peak 9.0–9.1). Pre-PTA was activated directly by activated Hageman factor or by Hageman factor prealbumin fragments. Its coagulant activity was inhibited by DFP, soybean trypsin inhibitor and trasylol but not by lima bean trypsin inhibitor or ovomucoid trypsin inhibitor indicating that activated PTA possesses the same inhibition profile utilizing these reagents as does plasma kallikrein. A major plasma inhibitor of activated PTA was found to be a 65,000 mol wt α-globulin which was isolated free of α(1)-chymotrypsin inhibitor, inter α-trypsin inhibitor, α(2)-macroglobulin, and the other known inhibitors of activated PTA, the activated first component of complement (C1 INH), and antithrombin III. Its physicochemical properties were identical to α(1)-antitrypsin, and it was absent in α(1)-antitrypsin-deficient plasma thereby identifying this PTA inhibitor as α(1)-antitrypsin. The Rockefeller University Press 1974-11-30 /pmc/articles/PMC2139762/ /pubmed/4547783 Text en Copyright © 1974 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Heck, Louis W.
Kaplan, Allen P.
SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
title SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
title_full SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
title_fullStr SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
title_full_unstemmed SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
title_short SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
title_sort substrates of hageman factor : i. isolation and characterization of human factor xi (pta) and inhibition of the activated enzyme by α(1)-antitrypsin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139762/
https://www.ncbi.nlm.nih.gov/pubmed/4547783
work_keys_str_mv AT hecklouisw substratesofhagemanfactoriisolationandcharacterizationofhumanfactorxiptaandinhibitionoftheactivatedenzymebya1antitrypsin
AT kaplanallenp substratesofhagemanfactoriisolationandcharacterizationofhumanfactorxiptaandinhibitionoftheactivatedenzymebya1antitrypsin